Search Results 901-910 of 16396 for monoclonal antibody

  1. Selective IgA deficiency - Symptoms and causes - Mayo Clinic

    An immunoglobulin is an antibody produced by immune system cells to fight bacteria, parasites and other agents that cause illness. IgA antibodies circulate ...

  2. Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer - Mayo Clinic

    ... monoclonal antibody, small molecule pathway inhibitor). Treatment with systemic corticosteroid or immune-modulators ≤ 7 days prior to randomization ...

  3. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

    ... antibody HJ8.5. We sought to determine the effects of ... monoclonal antibodies for their ability to block seeding activity present in P301S brain lysates.

  4. Biomarker-guided CNI substitution in Kidney Transplantation Assessment - Mayo Clinic

    anti-Tumor necrosis factor(TNF) Monoclonal antibodies (mAb), or Belatacept, abatacept, ... Positive for a Donor Specific Antibody (DSA) 0-6 months post-kidney ...

  5. A Study to Assess the Effectiveness, Safety and Tolerability of Lu AF82422 in Patients with Multiple System Atrophy - Mayo Clinic

    - The participant has been treated with an anti-?-synuclein monoclonal antibody, mesenchymal stem cells or an inhibitor of ?-synuclein aggregation within ...

  6. Bone Marrow Transplant Clinical Trials

    Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...

  7. A Study of the Efficacy and Safety of Belimumab Compared to Placebo in Adults With Systemic Sclerosis Associated Interstitial Lung Disease - Mayo Clinic

    Anticentromere antibody negative on central test at screening. 7. Evidence ... Treatment with biologic agents, such as intravenous immunoglobulin or monoclonal

  8. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    Monoclonal antibodies (anti-CD38 and anti-SLAMF7 antibody) within 4 weeks prior to leukapheresis;; Any other systemic therapy approved for the treatment of ...

  9. Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Mayo Clinic

    No more than 3 prior regimens for large cell component (e.g., one induction and two salvage therapies); monoclonal antibody alone or involved field/involved ...

  10. Overview - Transplant Immunology Program - Mayo Clinic Research

    The Transplant Immunology Program at Mayo Clinic is overcoming antibody-related organ rejection, improving long-term outcomes and forging key partnerships.